Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Deneberg

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2012
Epigenetics in myeloid malignanciesStefan Deneberg
Cancers|April 14, 2026
A Current Overview of Quality-of-Life Research in Chronic Myeloid Leukemia (CML)Stefan Deneberg
Frontiers in Oncology|November 24, 2025
Resistance to imatinib in a <i>ETV6::PDGFRB</i> rearranged myeloid/lymphoid neoplasm with high-risk mutations: a case reportLucia Cavelier, Leonie Saft, Birgitta Sander, et al.
Medical Oncology (Northwood, London, England)|September 18, 2007
Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use?Stefan Deneberg, Richard Lerner, Per Ljungman, et al.
The Journal of Rheumatology|August 19, 2007
Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized studyIngiäld Hafström, Morteza Rohani, Stefan Deneberg, et al.
European Journal of Haematology|December 1, 2010
APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cellsDina Ali, Kerstin Jönsson-Videsäter, Stefan Deneberg, et al.
Cancer Chemotherapy and Pharmacology|October 26, 2007
The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemiaLars Möllgård, Stefan Deneberg, Hareth Nahi, et al.
Oncology Reports|June 11, 2009
Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantationEsbjörn Paul, Tolga Sutlu, Stefan Deneberg, et al.
Blood|April 2, 2020
AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor bindingHuthayfa Mujahed, Sophia Miliara, Anne Neddermeyer, et al.
Blood Advances|December 1, 2023
Clinical and immunological features in ACKR1/DARC-associated neutropeniaJan Palmblad, Ebba Sohlberg, Christer C Nilsson, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2012
Epigenetics in myeloid malignanciesStefan Deneberg
Cancers|April 14, 2026
A Current Overview of Quality-of-Life Research in Chronic Myeloid Leukemia (CML)Stefan Deneberg
Frontiers in Oncology|November 24, 2025
Resistance to imatinib in a <i>ETV6::PDGFRB</i> rearranged myeloid/lymphoid neoplasm with high-risk mutations: a case reportLucia Cavelier, Leonie Saft, Birgitta Sander, et al.
Medical Oncology (Northwood, London, England)|September 18, 2007
Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use?Stefan Deneberg, Richard Lerner, Per Ljungman, et al.
The Journal of Rheumatology|August 19, 2007
Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized studyIngiäld Hafström, Morteza Rohani, Stefan Deneberg, et al.
European Journal of Haematology|December 1, 2010
APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cellsDina Ali, Kerstin Jönsson-Videsäter, Stefan Deneberg, et al.
Cancer Chemotherapy and Pharmacology|October 26, 2007
The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemiaLars Möllgård, Stefan Deneberg, Hareth Nahi, et al.
Oncology Reports|June 11, 2009
Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantationEsbjörn Paul, Tolga Sutlu, Stefan Deneberg, et al.
Blood|April 2, 2020
AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor bindingHuthayfa Mujahed, Sophia Miliara, Anne Neddermeyer, et al.
Blood Advances|December 1, 2023
Clinical and immunological features in ACKR1/DARC-associated neutropeniaJan Palmblad, Ebba Sohlberg, Christer C Nilsson, et al.
Pageof 3